Displaying 1 - 11 of 11
| Active Ingredient | BECLOMETHASONE DISODIUM PHOSPHATE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Local treatment of inflammation. Must be prescribed by an ophthalmologist. |
| Caution | Use for short periods of time. Prolonged use can cause herpetic corneal disease and "steroid glaucoma". |
| Dose Range | instill One drop 4 times daily. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BETAMETHASONE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Local treatment of inflammation. Must be prescribed by an ophthalmologist. |
| Caution | Use for short periods of time. Prolonged use can cause herpetic corneal disease and "steroid glaucoma". |
| Dose Range | One drop 4 times daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BETAMETHASONE DISODIUM PHOSPHATE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications |
Local treatment of inflammation. Must be prescribed by an ophthalmologIst. |
| Caution | Use for short periods of time. Prolonged use can cause herpetic corneal disease and "steroid glaucoma". |
| Dose Range | One drop 4 times daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BUDESONIDE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Rhinitis. |
| Caution | Not recommendedin children under 6 years. Non-halogenated corticosteroid. See under beclomethasone. |
| Dose Range | Adults and Children over 6 years: 2 sprays into each nostril oncedaily in the morning or 1 spray into each nostril twice daily; maintainence: 1 spray into each nostril once daily . See BDS supply protocols pg. 11. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DEXAMETHASONE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Short term treatment of inflammation. Must be prescribed by an ophthalmologist. |
| Caution | |
| Dose Range | One drop 4 times daily |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FLUNISOLIDE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Prophylaxis and treatment of allergic rhinitis. |
| Caution | Loss of taste or smell, nausea, vomiting, dyspepsia, headache, dizziness, nasal irritation. |
| Dose Range | Adult and children 14 years and over: 2 spray s (25mcg/sp ray ) in each nostril twice daily , increased if necessary to max. 3 times daily then reduced for maintenance. Pediatric 5-14 years: Initially 1 sp ray (25mcg) into each nostril up to 3 time |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FLUOROMETHOLONE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Allergic and inflammatory conditions of the eye. |
| Caution | Raised intra-ocular pressure with prolonged use. |
| Dose Range | Adult and children over 2: Apply every 1 hour for 24-48 hours, then reduced to 2-4 times a day . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FLUTICASONE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Prophylaxis and treatment of allergic rhinitis and perennial rhinitis and nasal polyps. |
| Caution | Nasal ulceration, dryness, irritation of nose and throat, and epistaxis. Not recommended in children under 2 y ears. |
| Dose Range |
Adults and children over 12 years: 2 sp ray s (55mcg) in each nostril once daily , reducing to 1 sp ray (27.5mcg) once daily once adequate control of symptoms is achieved. Pediatric 2 -12 years: 1 spray in each nostril once daily . See BDS supply pr |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | MOMETASONE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Prophylaxis and treatment of allergic rhinitis |
| Caution | Headache, pharyngitis, epistaxis, cough, dysmenorrhea, nasal burning. Store spray away from light. |
| Dose Range | Adults and children 12 years and over: 2 sp ray s in each nostril once daily , increasing to 4 sp ray s once daily if needed. Decrease to one sp ray once daily as a maintenance dose. Pediatric (2-11 years): 1 sp ray into each nostril once da |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PREDNISOLONE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Long-term therap y should be avoided. |
| Caution | Long-term therap y should be avoided. |
| Dose Range | 1-2 drops every hour during the day and every 2 hours during the night for initial therapy in severe cases. In mild or moderate inflammation or when a favorable resp onse is attained in severe cases, dosage may be reduced to 1 or 2 drops every |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | TRIAMCINOLONE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Treatment of seasonal and perennial allergic rhinitis. |
| Caution | Headache occurred in 18% of patients receiving intranasal triamcinolone. Other adverse effects included nasal irritation, dry mucous membranes, congestion, throatdiscomfort, sneezing. No More ... |
| Dose Range | Adults and Children 12 years and over: 2 sprays in each nostril once daily, decrease to one spray once daily as a maintenance dose. Pediatric (6-12 years): 1 sp ray into each nostril once daily. See BDS supply protocols pg. 11. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |